pixantrone has been researched along with Heart Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cernohous, P; Engert, A; Herbrecht, R; Le Gouill, S; Macdonald, D; Machida, C; Myint, H; Saleh, A; Singer, J; van der Jagt, R; Wilhelm, M | 1 |
1 trial(s) available for pixantrone and Heart Failure
Article | Year |
---|---|
Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Heart Failure; Humans; Isoquinolines; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Stroke Volume; Survival; Survival Rate; Topoisomerase II Inhibitors; Treatment Outcome; Troponin T; Vincristine | 2013 |